Intra-Cellular Therapies (I2TC34.SA) Q1 2025 Earnings

21FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.61
-1.21
-0.82
-0.42

Details

Expected EPS
-0.42208891559999995
Actual EPS
-0.9171360000000001
Surprise EPS
-0.5
Surprise Percent
+117.29%

Description

Intra-Cellular Therapies (I2TC34.SA) has reported earnings of -0.9171360000000001 per share for Q1 2025.

0 Comments

Share your thoughts